Plasma renin activity, plasma angiotensin II and extracellular fluid volume in patients after renal transplantation. 1976

J S Horvath, and C Baxter, and F Furby, and V Hood, and J Johnson, and B McGrath, and D J Tiller

1. Patients with cadaveric renal transplants and plasma creatinine less than 177 micronmol/l who had their own kidneys removed were studied. 2. The renin-angiotensin system appeared to behave in a normal fashion in response to alterations in sodium intake and posture. 3. The renin-angiotensin system had no major role in the establishment or maintenance of hypertension. 4. Mean arterial pressure was directly related to expansion of the extracellular fluid volume.

UI MeSH Term Description Entries
D008297 Male Males
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D005110 Extracellular Space Interstitial space between cells, occupied by INTERSTITIAL FLUID as well as amorphous and fibrous substances. For organisms with a CELL WALL, the extracellular space includes everything outside of the CELL MEMBRANE including the PERIPLASM and the cell wall. Intercellular Space,Extracellular Spaces,Intercellular Spaces,Space, Extracellular,Space, Intercellular,Spaces, Extracellular,Spaces, Intercellular
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D012964 Sodium A member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23. Sodium Ion Level,Sodium-23,Ion Level, Sodium,Level, Sodium Ion,Sodium 23
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal

Related Publications

J S Horvath, and C Baxter, and F Furby, and V Hood, and J Johnson, and B McGrath, and D J Tiller
August 1992, Transplantation proceedings,
J S Horvath, and C Baxter, and F Furby, and V Hood, and J Johnson, and B McGrath, and D J Tiller
January 1976, Archives of internal medicine,
J S Horvath, and C Baxter, and F Furby, and V Hood, and J Johnson, and B McGrath, and D J Tiller
April 1979, Klinische Wochenschrift,
J S Horvath, and C Baxter, and F Furby, and V Hood, and J Johnson, and B McGrath, and D J Tiller
January 1969, Atti della Societa italiana di cardiologia,
J S Horvath, and C Baxter, and F Furby, and V Hood, and J Johnson, and B McGrath, and D J Tiller
January 1977, Verhandlungen der Deutschen Gesellschaft fur Kreislaufforschung,
J S Horvath, and C Baxter, and F Furby, and V Hood, and J Johnson, and B McGrath, and D J Tiller
September 1977, Scandinavian journal of clinical and laboratory investigation,
J S Horvath, and C Baxter, and F Furby, and V Hood, and J Johnson, and B McGrath, and D J Tiller
December 1969, Canadian journal of physiology and pharmacology,
J S Horvath, and C Baxter, and F Furby, and V Hood, and J Johnson, and B McGrath, and D J Tiller
August 1977, Lancet (London, England),
J S Horvath, and C Baxter, and F Furby, and V Hood, and J Johnson, and B McGrath, and D J Tiller
July 1978, Clinical science and molecular medicine,
J S Horvath, and C Baxter, and F Furby, and V Hood, and J Johnson, and B McGrath, and D J Tiller
June 1975, Clinical science and molecular medicine. Supplement,
Copied contents to your clipboard!